Drug equivalency data submission to be simplified

Published: 2004-03-23 06:59:00

Updated: 2004-03-23 06:59:00

KFDA plans to ease the drug equivalency review works by shortening the process and simplifying the necessary data to submit.

The Drug Review Division of KFDA indicated at the explanatory meeting for the drug review on March 18 at the auditorium of Korea Center for Disease Control and Preventi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK